Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

IceCure Medical Announces Independent Study Results For ProSense Cryoablation System Published In Peer-Reviewed Journal *Cancers*

Author: Benzinga Newsdesk | July 09, 2024 08:36am

Study Shows High Complete Ablation Rate And Satisfactory Overall Survival In Breast Cancer Patients; Conducted At University Hospital Frankfurt By Prof. Thomas J. Vogl, Study Highlights 8.9% Recurrence Rate In 45 Patients With Tumors Up To 4cm, Including High-Risk Population With Recurrent And Metastatic Disease

Posted In: ICCM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist